During this year’s event, participants could review the current state-of-the-art in lung cancer therapy, update their knowledge in prevention, screening, detection and much more.

Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefited from its comprehensive and stimulating programme.

This virtual format managed to effectively disseminate the latest advances in lung and thoracic malignancies and give experts from all around the world the chance to identify promising new research avenues.